Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$49.63+0.03 (+0.06%)
Close on Nov 20, 2026Market cap $2.35BP/E 13.9Yield –
Prestige Consumer Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Prestige Consumer Healthcare's revenue for the twelve months ending Jun 30, 2026 was $1.10B, down 1.4% year over year. For fiscal 2026 it was $1.09B, down 4.3% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $1.14B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.09B | -4.3% |
| FY2025 | Mar 31, 2025 | $1.14B | +1.1% |
| FY2024 | Mar 31, 2024 | $1.13B | -0.2% |
| FY2023 | Mar 31, 2023 | $1.13B | +3.8% |
| FY2022 | Mar 31, 2022 | $1.09B | +15.2% |
| FY2021 | Mar 31, 2021 | $943.37M | -2.0% |
| FY2020 | Mar 31, 2020 | $963.01M | -1.3% |
| FY2019 | Mar 31, 2019 | $975.78M | -6.3% |
| FY2018 | Mar 31, 2018 | $1.04B | +18.0% |
| FY2017 | Mar 31, 2017 | $882.06M | +9.4% |
| FY2016 | Mar 31, 2016 | $806.25M | +12.8% |
| FY2015 | Mar 31, 2015 | $714.62M | +19.6% |
| FY2014 | Mar 31, 2014 | $597.38M | -3.2% |
| FY2013 | Mar 31, 2013 | $616.92M | +39.9% |
| FY2012 | Mar 31, 2012 | $441.09M | +31.1% |
| FY2011 | Mar 31, 2011 | $336.51M | +15.0% |
| FY2010 | Mar 31, 2010 | $292.60M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $265.71M | +6.5% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $281.62M | -5.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $283.44M | -2.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $274.11M | -3.4% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $249.53M | -6.6% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $296.52M | +7.0% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $290.32M | +2.7% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $283.79M | -0.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $267.14M | -4.4% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $276.99M | -3.1% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $282.74M | +2.6% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $286.32M | -1.0% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $279.31M | +0.8% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $285.87M | +7.1% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $275.52M | +0.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $289.27M | +4.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $277.06M | +2.9% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $266.94M | +12.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $274.47M | +14.9% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $276.23M | +16.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $269.18M | +17.3% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $237.76M | -5.4% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $238.79M | -1.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $237.42M | -0.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $229.39M | -1.2% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $251.24M | +4.2% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $241.55M | +0.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $238.07M | -0.5% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $232.15M | -8.6% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $241.03M | -5.8% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $241.41M | -10.8% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $239.36M | -7.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $253.98M | -1.0% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $255.97M | +6.4% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $270.62M | +24.8% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $258.03M | +20.0% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $256.57M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $240.67M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $216.76M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $215.05M | – |
See a number that looks wrong?